India, May 21 -- Tevogen Bio Holdings Inc. (TVGN), a healthcare enterprise integrating biotechnology and AI, announced it has signed a non-exclusive, non-binding Letter of Intent to evaluate a potential acquisition of Management Services Organization (MSO).
If completed, the transaction could expand Tevogen's infrastructure and support its evolution into a revenue-generating enterprise, combining Tevogen Bio, Tevogen.AI, and a healthcare services arm with management and contract research operations. CEO Ryan Saadi stated that the opportunity, together with other strategic initiatives, could potentially pave the path toward approximately $100 million in combined annual revenue.
The deal remains subject to due diligence, negotiation of defi...